[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fSDVhyo3J4pnalUGwxMYRIm5rQVnsWfdEOfo_5tTOpS0":8,"$f_qSsh0-sAEsXcM2tfjtEz3q-DxEVxpSjzskI34a-qxM":54,"$fZ1NXIfSIhBaL2-Zvl0UxFB06rDS8b-s7U_rnON_nv9s":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":53},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":6,"materialTotal":19,"videoTotal":20,"isConcern":7,"title":21,"coverVertical":17,"coverAcross":22,"content":23,"description":24,"views":25,"likes":20,"isThumbsUp":7,"isCollection":7,"collections":20,"createTime":26,"seoTitle":27,"seoKeywords":28,"seoDescription":29,"shelvesTime":30,"version":31,"menus":32,"menuId":34,"type":41,"quality":52,"commentCount":20,"isComment":6},61158,869853,[],"https://cdn.yishi-tong.com/console/store-15/yYkq2SrD3mCA_mIycDr_z0sXJo2MNmaF.png","导管指挥处","","介入治疗科",206,0,"肿瘤导管介入治疗：现代医学的精准利器","https://ystcdn.venuertc.com/venue/AI/0bfecb16-fad7-403c-adb4-dd70d49eba23.jpg","\u003Cdiv class=\"material-container\">   \u003Ch1 id=\"material_title\" class=\"material-title\">肿瘤导管介入治疗：现代医学的精准利器\u003C/h1>   \u003Cdiv class=\"material-section material-bg-01\">     \u003Ch2 class=\"material-subtitle\">01 导管介入治疗是什么？说给普通人听\u003C/h2>     \u003Cp>“你听说过肿瘤导管介入治疗吗？”有不少人第一次听见会疑惑，这名字挺专业，但什么场合用得到呢？简单来说，这项技术就是用一根细管，直接把药送进肿瘤周围——有点像送快递，按地址精准投递。发展到现在，已经成了不少肿瘤医院的常规做法，尤其是针对一些不能手术切除的病灶。介入治疗的作用，就是让肿瘤局部“下线”、整体副损伤又很小，让治疗更加有的放矢。\u003C/p>     \u003Cp>其实，大家平时没少听到“精准医学”这个词。导管介入，就是把精准落实到操作细节里的一个典型例子。从早期的外科手术，到现在微创和局部治疗并行，这条路上的每一步，都是给患者增加了一些新的选择，也让希望多了一份可能。\u003C/p>     \u003Cdiv class=\"material-tips material-bg-tip\">       \u003Cspan>🔍 \u003Cstrong>TIPS:\u003C/strong> 导管介入治疗并不是所有肿瘤通用，也不是万能，每一步都需要专科医生严格把关。\u003C/span>     \u003C/div>   \u003C/div>    \u003Cdiv class=\"material-section material-bg-02\">     \u003Ch2 class=\"material-subtitle\">02 治疗原理拆解：怎么“精准打击”肿瘤？\u003C/h2>     \u003Cp>导管这个细小的工具，就是肿瘤治疗中的“定点快递员”。主要办法有三种：药物灌注、微粒栓塞、以及局部化疗。常见原理如下：\u003C/p>     \u003Ctable class=\"material-table\">       \u003Ctr>         \u003Cth>技术手段\u003C/th>         \u003Cth>具体做法\u003C/th>         \u003Cth>生活类比\u003C/th>       \u003C/tr>       \u003Ctr>         \u003Ctd>药物灌注\u003C/td>         \u003Ctd>把药直接通过导管注入肿瘤供血血管\u003C/td>         \u003Ctd>好像修水管时只给漏水点加补丁\u003C/td>       \u003C/tr>       \u003Ctr>         \u003Ctd>微粒栓塞\u003C/td>         \u003Ctd>用微粒堵住为肿瘤供血的小血管\u003C/td>         \u003Ctd>类似拦住“偷粮车”的路\u003C/td>       \u003C/tr>       \u003Ctr>         \u003Ctd>局部化疗\u003C/td>         \u003Ctd>高浓度药物只作用于肿瘤周围\u003C/td>         \u003Ctd>像用喷雾专门对付小范围污渍\u003C/td>       \u003C/tr>     \u003C/table>     \u003Cp>这些技术的好处，是可以针对不同病情调整方案。比如一位55岁的男性肝癌患者，手术风险很高，医生就选择了介入栓塞联合化疗，肿瘤区域缩小，全身副作用很低。这种定制化操作，是导管介入“专人专送”的精髓。\u003C/p>   \u003C/div>    \u003Cdiv class=\"material-section material-bg-03\">     \u003Ch2 class=\"material-subtitle\">03 哪些肿瘤适合做导管介入？\u003C/h2>     \u003Cp>不是每种肿瘤都用得上介入治疗，主要适合以下几类：\u003C/p>     \u003Cul class=\"material-list\">       \u003Cli>\u003Cstrong>肝癌\u003C/strong>：原发性肝癌、部分转移性肝癌，特别是手术不可切除者。\u003C/li>       \u003Cli>\u003Cstrong>肺部肿瘤\u003C/strong>：部分肺癌可选介入做辅助，尤其是肿瘤局限时。\u003C/li>       \u003Cli>\u003Cstrong>肾脏和胰腺肿瘤\u003C/strong>：定位清晰、局部病灶可控。\u003C/li>       \u003Cli>\u003Cstrong>骨肿瘤与实体瘤转移\u003C/strong>：如骨转移、软组织肿瘤局部。\u003C/li>     \u003C/ul>     \u003Cp>比如有位72岁的女性，胰腺肿瘤不能切除，医生就采用了局部介入栓塞，肿瘤生长速度明显降低，后续结合其他治疗方案提升了整体效果。\u003C/p>     \u003Cdiv class=\"material-tips material-bg-tip\">       \u003Cspan>🌱 导管介入适合不能手术、单一药物效果有限或患者无法耐受传统治疗者。\u003C/span>     \u003C/div>   \u003C/div>    \u003Cdiv class=\"material-section material-bg-04\">     \u003Ch2 class=\"material-subtitle\">04 疗效怎么判断？改善了病情还是只减轻症状？\u003C/h2>     \u003Cp>效果好坏怎么看？其实要看几个关键标准：\u003C/p>     \u003Cdiv class=\"material-table-responsive\">       \u003Ctable class=\"material-table\">         \u003Ctr>           \u003Cth>评估标准\u003C/th>           \u003Cth>具体内容\u003C/th>         \u003C/tr>         \u003Ctr>           \u003Ctd>影像检查\u003C/td>           \u003Ctd>肿瘤缩小、坏死、或稳定不增长（CT/MRI）\u003C/td>         \u003C/tr>         \u003Ctr>           \u003Ctd>临床症状\u003C/td>           \u003Ctd>疼痛减轻、生活质量改善，如体力、饮食变好\u003C/td>         \u003C/tr>         \u003Ctr>           \u003Ctd>生化指标\u003C/td>           \u003Ctd>部分肿瘤相关指标下降（如AFP、CEA）\u003C/td>         \u003C/tr>       \u003C/table>     \u003C/div>     \u003Cp>比如一位60岁的男性肺癌患者，介入治疗两周后呼吸顺畅多了，影像显示肿瘤缩小30%。这说明治疗不只是缓解症状，更在持续减小肿瘤负担。对不少人来说，生活质量的提升比单纯的肿瘤指标变化更“接地气”。\u003C/p>   \u003C/div>    \u003Cdiv class=\"material-section material-bg-05\">     \u003Ch2 class=\"material-subtitle\">05 风险与并发症：哪些问题需要特别小心？\u003C/h2>     \u003Cp>多数导管介入治疗是微创，不等于完全无风险。下面这些情况要关注：\u003C/p>     \u003Cul class=\"material-list material-bg-list\">       \u003Cli>\u003Cstrong>感染风险：\u003C/strong>导管穿刺处偶尔红肿，要注意消毒护理。\u003C/li>       \u003Cli>\u003Cstrong>出血问题：\u003C/strong>极少数人因血管脆弱可能出血，适合前期检查血小板。\u003C/li>       \u003Cli>\u003Cstrong>药物反应：\u003C/strong>部分患者用药后有短时发热或不适，应随访观察。\u003C/li>       \u003Cli>\u003Cstrong>局部疼痛或淤血：\u003C/strong>早期短暂不适，必要时用镇痛药辅助。\u003C/li>     \u003C/ul>     \u003Cp>例如一位48岁的男性肾癌患者，术后一天出现低热，及时处理后无大碍。这类反应虽有，通常都可通过监测和医学干预快速缓解。总的来说，重大并发症较少，但日常观察和术后护理仍不可掉以轻心。\u003C/p>   \u003C/div>    \u003Cdiv class=\"material-section material-bg-06\">     \u003Ch2 class=\"material-subtitle\">06 怎么预防并且“合作”让疗效达到最好？\u003C/h2>     \u003Cp>积极配合治疗、改善日常饮食和生活习惯，对促进康复很重要。以下是可以具体操作的建议：\u003C/p>     \u003Cdiv class=\"material-table-responsive\">       \u003Ctable class=\"material-table\">         \u003Ctr>           \u003Cth>建议措施\u003C/th>           \u003Cth>具体做法\u003C/th>         \u003C/tr>         \u003Ctr>           \u003Ctd>新鲜蔬果\u003C/td>           \u003Ctd>补充维生素和抗氧化物，可每日食用\u003C/td>         \u003C/tr>         \u003Ctr>           \u003Ctd>优质蛋白\u003C/td>           \u003Ctd>鱼、豆制品、鸡蛋，有利于修复组织\u003C/td>         \u003C/tr>         \u003Ctr>           \u003Ctd>规律作息\u003C/td>           \u003Ctd>睡眠充足、避免过度劳累利于恢复\u003C/td>         \u003C/tr>         \u003Ctr>           \u003Ctd>定期复查\u003C/td>           \u003Ctd>术后2周内回访，后期每半年做1次相关影像\u003C/td>         \u003C/tr>       \u003C/table>     \u003C/div>     \u003Cp>其实，复查和沟通很要紧。有些人以为做完就“万事大吉”，实际上，后续管理和医生交流才是真正能拉长健康曲线的关键环节。很多医院都提供专门的随访服务，不妨多加利用。\u003C/p>     \u003Cdiv class=\"material-tips material-bg-tip\">       \u003Cspan>📝 \u003Cstrong>TIPS:\u003C/strong> 一旦发现身体明显不适或持续高热，应尽快返回诊室，不要拖延。\u003C/span>     \u003C/div>   \u003C/div>    \u003Cdiv class=\"material-section material-bg-07\">     \u003Ch2 class=\"material-subtitle\">07 展望未来——肿瘤导管介入的发展趋势\u003C/h2>     \u003Cp>说起来，这种治疗方式的进步空间还很大。未来，结合AI影像辅助诊断、纳米药物和更加智能化的导管技术，可能让疗效更精准、副作用更低。同时，更多临床研究正在快速推进，比如近年《Journal of Oncology》刊登的综述（Zhi-yuan Qiu et al., 2023）指出，局部微创技术对肝癌等实体瘤显著改善了生存率。\u003C/p>     \u003Cdiv class=\"material-tips material-bg-tip\">       \u003Cspan>🚀 及时关注权威医学新动态，能帮自己抓住更多可靠选择。\u003C/span>     \u003C/div>     \u003Cp>肿瘤治疗领域变化很快，导管介入不是终点，而是让希望持续的一种方式。家里有人遇到相关病情，可以主动咨询专业的肿瘤科或介入医学团队，得到更定制化的方案支持。\u003C/p>   \u003C/div>    \u003Cdiv class=\"material-section material-bg-ref\">     \u003Ch3 class=\"material-ref-title\">参考文献\u003C/h3>     \u003Cul class=\"material-ref-list\">       \u003Cli>         Zhi-yuan Qiu, Wen-Li Wang, et al. (2023). Advances in interventional therapy for primary and metastatic liver cancer. \u003Ci>Journal of Oncology\u003C/i>.       \u003C/li>       \u003Cli>         Lencioni R, Crocetti L. (2022). Local-regional treatment of hepatocellular carcinoma. \u003Ci>Radiology\u003C/i>, 305(2):345–361.       \u003C/li>       \u003Cli>         De Baere T, Arai Y, et al. (2020). Interventional oncology: new frontiers for liver cancer management. \u003Ci>Nature Reviews Clinical Oncology\u003C/i>, 17:733–745.       \u003C/li>     \u003C/ul>   \u003C/div> \u003C/div>  \u003Cstyle> .material-container {   font-family: \"PingFang SC\", \"Microsoft YaHei\", Arial, sans-serif;   margin: 40px auto;   max-width: 820px;   background: #fafbfc;   border-radius: 15px;   box-shadow: 0 4px 18px 0 rgba(150,180,200,.11);   padding: 32px 22px 40px 22px; } .material-title {   font-size: 2.2rem;   font-weight: bold;   color: #285579;   text-align: center;   margin-bottom: 32px;   letter-spacing: .04em; }  /* Section backgrounds */ .material-section {   border-radius: 11px;   margin-bottom: 28px;   padding: 24px 22px 14px 22px; } .material-bg-01 { background: linear-gradient(90deg, #f6fbff 50%, #eef4ff 100%);} .material-bg-02 { background: linear-gradient(90deg, #fdfaf5 45%, #f7f6ef 100%);} .material-bg-03 { background: linear-gradient(90deg, #f6fff9 60%, #eaffef 100%);} .material-bg-04 { background: linear-gradient(90deg, #fffbf6 55%, #f7f2ef 100%);} .material-bg-05 { background: linear-gradient(90deg, #f8fcfd 70%, #e4f3f5 100%);} .material-bg-06 { background: linear-gradient(90deg, #fafaf8  60%, #f3faea 100%);} .material-bg-07 { background: linear-gradient(90deg, #fffafa 40%, #ffeaff 100%);} .material-bg-ref { background: #f6f9fc; border: 1px solid #e3edf5;}  /* Subtitles */ .material-subtitle {   font-size: 1.32rem;   font-weight: 600;   color: #3b4768;   letter-spacing: 0.005em;   margin-bottom: 16px; } .material-ref-title {   font-size: 1rem;   font-weight: 600;   color: #29729a;   margin-bottom: 10px;   margin-top: 3px; }  /* List style */ .material-list {   margin: 8px 0 10px 0;   padding-left: 20px; } .material-list li {   margin: 7px 0 0 5px;   line-height: 1.5;   font-size: 1.07rem; } .material-bg-list li {   background: #f2f6fb;   border-radius: 6px;   padding: 5px 12px 5px 7px; }  /* Table style */ .material-table-responsive {overflow-x:auto;} .material-table {   width: 100%;   border-collapse: collapse;   margin-top: 13px;   margin-bottom: 9px;   font-size: 1.01rem; } .material-table th, .material-table td {   border: 1px solid #e3e3ed;   padding: 8px 12px;   text-align: left; } .material-table th {   background-color: #eef3f8;   font-weight: bold; } .material-table tr:nth-child(even) td {   background-color: #f9fbfd; }  /* Tips style */ .material-tips {   margin: 13px 0 6px 0;   padding: 9px 14px;   border-radius: 8px;   background: #f2f8fe;   color: #215286;   font-size: 1rem;   box-shadow: 0 0 7px 0 rgba(120,150,170,.07);   font-family: inherit; }  /* Reference */ .material-ref-list {   padding-left: 20px;   margin-top: 6px;   margin-bottom: 8px; } .material-ref-list li {   font-size: 0.99rem;   color: #474f61;   margin: 4px 0; }  /* Responsive */ @media (max-width: 520px) {   .material-container {     padding: 10px 4px 26px 4px;     max-width: 99vw;   }   .material-title {     font-size: 1.36rem;     margin-top: 16px;     margin-bottom: 18px;   }   .material-section {     padding: 10px 5px 5px 10px;   }   .material-table th, .material-table td {     padding: 5px 7px;     font-size: 0.98rem;   } } \u003C/style>","本文深入探讨了肿瘤导管介入治疗的机制、适用类型、疗效评估以及潜在风险，为患者提供了一种个性化的肿瘤治疗选择，未来展望也指向更高的疗效和更低的副作用。",562,"2025-08-20 12:05:06","肿瘤导管介入治疗：现代医学的精准利器 - 微创高效治疗方案  \n","肿瘤导管介入治疗,微创肿瘤治疗,精准介入手术,导管治疗癌症,现代医学介入技术,肿瘤靶向治疗  \n","肿瘤导管介入治疗是现代医学的精准微创技术，通过导管直达病灶进行靶向治疗，具有创伤小、恢复快、疗效显著等优势。本文详解其原理、适应症及技术进展，为患者提供高效治疗方案选择。","2025-08-21 07:38:00",2,[33],{"menuId":34,"menuName":35,"parentId":20,"orderNum":31,"path":36,"component":37,"isFrame":38,"isCache":39,"menuType":40,"visible":41,"status":20,"createDept":6,"remark":17,"createTime":42,"children":43,"columnImage":44,"columnLogo":45,"uncheckedLogo":6,"checkedLogo":6,"isHot":41,"isHome":20,"forceLogin":20,"color":46,"seoTitle":47,"seoKeywords":48,"seoDescription":49,"contentNum":6,"promotionalPoster":50,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":51,"routerPath":36,"componentInfo":37},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":55,"success":53},{"pageNo":41,"pageSize":56,"result":57,"totalSize":20},10,[],{"code":9,"msg":10,"message":6,"data":59,"success":53},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]